Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study - Wikidata - wikimedia - TriplyDB

Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study

Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study

http://www.wikidata.org/entity/Q35303221

about

PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology Monitoring the biological activity of abdominal aortic aneurysms Beyond Ultrasound Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque Exploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET)Non-invasive imaging of atherosclerosis Glucose metabolic trapping in mouse arteries: nonradioactive assay of atherosclerotic plaque inflammation applicable to drug discovery PET imaging detection of macrophages with a formyl peptide receptor antagonist High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics.Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies.Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.Progress in atherosclerotic plaque imaging.Multimodality cardiovascular molecular imaging technology.Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study.Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.(18)F-FDG PET and vascular inflammation: time to refine the paradigm?Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability.Aortic ¹⁸F-FDG uptake in patients suffering from granulomatosis with polyangiitis.(18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study.Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake 18FDG PET-CT imaging detects arterial inflammation and early atherosclerosis in HIV-infected adults with cardiovascular disease risk factors Extent of flow recirculation governs expression of atherosclerotic and thrombotic biomarkers in arterial bifurcations.Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography.Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis Positron emission tomography imaging of coronary atherosclerosis.Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study.An update on markers of carotid atherosclerosis in patients with Type 2 diabetes.Molecular imaging of atherosclerosis in translational medicine.Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation.What is the relationship between ¹⁸F-FDG aortic aneurysm uptake on PET/CT and future growth rate?Vascular imaging with positron emission tomography.PET imaging of aortic atherosclerosis: Is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality?Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?

P2860

Q26750798-8A4CAC2E-86F6-4273-92C0-F08CDB84DFEB Q26765979-27D20A30-34C9-4049-8570-BAFA1B574490 Q26781838-7475A4B0-5D8A-41F4-A3D2-42211DB33C1C Q26824883-33A8E319-4744-4577-8DA6-344ED85EA732 Q26852635-D7BC9C82-22E8-4162-95BD-F56514EAC951 Q26992143-4F96CDCA-BA00-4C8E-BDA4-842B5CA9DA5F Q28485353-3F947C9A-F128-4CB0-91A4-C4626F9D23E5 Q30301085-D039A49E-9BC5-4134-9B4D-B6B137139E04 Q30355172-D0AB7B9D-EB8B-49F7-97E9-1CC8EC32E1DF Q30401532-8E83FE92-EF8D-46C6-AE46-EFCA25FC9FED Q30436195-E6FB348F-9539-4C3C-9436-62D59B604B64 Q30464390-C6015079-1E92-405C-8255-90F4D084DEE7 Q30477993-DEC60A10-B962-4F83-B6E2-D7A6B8CF477C Q33624371-F79D7B72-15FC-4432-8BA8-68A80A8A4D11 Q33695086-A4209054-AC95-45A3-B223-0D64E5FC1336 Q33719962-1AAC9709-7885-4650-B261-560E7014DD5A Q33994603-DC381835-B9D5-436A-BCCA-F36FE3FF2ED7 Q34120778-A912DE8D-21FE-4B63-9BC9-BB213B5A73C7 Q34694001-12540F70-264E-4A44-AE04-7DE8A829B8F5 Q35556624-EB748DC0-8FEE-4A3C-BE0F-BBCA2477D3DB Q35577419-94DE47B4-0CBC-4894-BD88-0CC881346E37 Q35851713-2BF69730-C3E3-4102-BA13-2E78090B05DD Q35896196-9CFF91C1-D32F-40BE-88E1-5992E0E9E948 Q36083402-5630F584-1CC8-48F9-B0A9-C615B6B53D69 Q36311889-34E13D14-5555-434B-8D7C-4D9D70F67C66 Q36349802-1970EF88-4A1C-43D6-B316-4B84975545BC Q36426832-529084B2-3595-4187-9999-E4A385E8D897 Q36434865-2E564B9E-7211-4178-A531-8A971115F3E1 Q36792762-06F09C25-362F-41B7-8FA4-85216884ACB9 Q37043341-57BD853B-B960-48EB-9C29-56BC9C419168 Q37050963-2D9DAA46-849C-4756-9B36-F349EB878EF3 Q37524039-0082E6BB-8F3A-4B57-A039-200D8B633E2C Q37779311-37AED285-C2BC-4B8E-9A28-4BA4AF9C40E8 Q37822690-72C2DEDD-FF90-40C3-B41A-1DB94D1B3886 Q37832982-7F9A726D-2D07-422F-88B9-238B1B1AF332 Q37850313-521C7BB8-B77F-4E09-894C-55279E23E272 Q37862133-FFD310A3-8EDC-4C23-86E1-C002559B7D79 Q37868709-5A24F9B2-C7D3-4477-9C35-B4E3CD8627B1 Q37873382-94AD505E-7820-4CD9-8E88-FA7CD43F2BA7 Q38000174-4F4CD76F-7927-4419-8431-E67E81F5F7A5

P2860

Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study

http://www.wikidata.org/entity/Q35303221

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Relationships among regional a ...... puted tomography imaging study

@ast

Relationships among regional a ...... puted tomography imaging study

@en

type

label

Relationships among regional a ...... puted tomography imaging study

@ast

Relationships among regional a ...... puted tomography imaging study

@en

prefLabel

Relationships among regional a ...... puted tomography imaging study

@ast

Relationships among regional a ...... puted tomography imaging study

@en

P1433

Q35303221-8F42D0D3-B0A1-4B78-960D-8D628756C1B1

P1476

Q35303221-10B862FD-2CE1-47EC-8CDB-9952BFC02ADC

P2093

Q35303221-0C199061-B201-4638-9CB1-91081FEBDFEE

Q35303221-343C641B-3443-4D8A-9085-CA51F64F623B

Q35303221-42EAC2F6-1219-492A-B0E1-3ABDE50D5095

Q35303221-4CDA4D61-668F-446B-87B3-68EE7E90DEDC

Q35303221-5D34D9E7-3A30-48C8-88E9-A6A9256929AE

Q35303221-8E860CAE-94EF-46D8-AD1C-A47299B32C55

P2860

Q35303221-1B38FA89-8E7B-4C67-85B2-5DC3BCE8628A

Q35303221-1E819D83-47C4-4BB5-9790-6CACEAACF214

Q35303221-1FABFB49-BAC2-4EB5-9770-6B1A6DD28C9F

Q35303221-1FB49164-BCFE-4B28-8145-B3EFA76FC73C

Q35303221-2F775A78-C9D9-4004-B74D-336A5DF63863

Q35303221-32F43368-AB32-4607-8172-1B06ED6A1B2E

Q35303221-3442D0DD-AF99-4B5F-8506-ADCC8E764705

Q35303221-34AA7013-34A5-477A-ABBD-8A563F5BC63E

Q35303221-3F4B301F-F872-4EC5-B12D-6D64DCC8F345

Q35303221-4C193A0F-8604-480B-A601-6352650A2C53

P304

Q35303221-ECDC331E-11F4-4E88-8AA6-CB207AE87FC8

P31

Q35303221-0D5471E9-BEA1-4D6C-BB0B-B13FAA94E02F

P356

Q35303221-B6EFE80D-96E8-4F79-AF7C-3B61A12DA3D0

P433

Q35303221-B5DF43FD-CD25-46D0-AAD5-BFEFD3D5EC29

P478

Q35303221-59A88242-E671-485C-B480-0CF990E67A7B

P50

Q35303221-306E8E5E-95B5-44B6-87E8-C6C3232F0C6B

Q35303221-344902EE-0463-4A5E-B6C3-393DF8402FDB

P577

Q35303221-61707870-C05F-42D7-AE16-5380FC1A2285

P5875

Q35303221-6D0571B2-0265-4270-AE56-7BCED08C1E2A

P698

Q35303221-2D4DA641-E265-464E-B730-12B3E71F5132

P921

Q35303221-9F8A6D10-005F-466E-867B-F94A16D994F1

P932

Q35303221-A68207EC-DFDC-4B76-940F-4C03657A4409

P356

CIRCIMAGING.108.811752

P1433

Circulation: Cardiovascular Imaging

P1476

Relationships among regional a ...... puted tomography imaging study

@en

P2093

Josef Machac

http://www.w3.org/2001/XMLSchema#string

Kelly S Myers

http://www.w3.org/2001/XMLSchema#string

Mark Woodward

http://www.w3.org/2001/XMLSchema#string

Michael E Farkouh

http://www.w3.org/2001/XMLSchema#string

Sameer Bansilal

http://www.w3.org/2001/XMLSchema#string

Zahi A Fayad

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Inflammation in atherosclerosis

From 2D PET to 3D PET: issues of data representation and image reconstruction.

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Serpins, the vasculature, and viral therapeutics.

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Adiponectin as an anti-inflammatory factor.

P304

107-115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCIMAGING.108.811752

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Valentín Fuster Carulla

P577

2009-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26875571

http://www.w3.org/2001/XMLSchema#string

P698

19808576

http://www.w3.org/2001/XMLSchema#string

P921

P932

3190196

http://www.w3.org/2001/XMLSchema#string